Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-24T12:35:52.395Z Has data issue: false hasContentIssue false
  • English
  • Français

Feasibility of collecting tumor samples of breast cancer patients diagnosed up to 50 years ago in the Child Health and Development Studies

Published online by Cambridge University Press:  06 March 2017

N. Y. Krigbaum ,
R. A. Rubin ,
P. M. Cirillo ,
M. B. Terry ,
L. A. Habel ,
C. Morris  and
B. A. Cohn
N. Y. Krigbaum*
Affiliation:
Child Health and Development Studies, Public Health Institute, Oakland, CA, USA
R. A. Rubin
Affiliation:
Child Health and Development Studies, Public Health Institute, Oakland, CA, USA
P. M. Cirillo
Affiliation:
Child Health and Development Studies, Public Health Institute, Oakland, CA, USA
M. B. Terry
Affiliation:
Columbia University, Mailman School of Public Health, New York, NY, USA
L. A. Habel
Affiliation:
Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
C. Morris
Affiliation:
California Cancer Reporting and Epidemiologic Surveillance Program, Institute for Population Health Improvement, UCD Health System, Sacramento, CA, USA
B. A. Cohn
Affiliation:
Child Health and Development Studies, Public Health Institute, Oakland, CA, USA
*
*Address for correspondence: N. Krigbaum, 1683 Shattuck Ave, Suite B, Berkeley, CA 94709-1611, USA. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Environmental exposures during pregnancy may increase breast cancer risk for mothers and female offspring. Tumor tissue assays may provide insight regarding the mechanisms. This study assessed the feasibility of obtaining tumor samples and pathology reports from mothers (F0) who were enrolled in the Child Health and Development Studies during pregnancy from 1959 to 1967 and their daughters (F1) who developed breast cancer over more than 50 years of follow-up. Breast cancer cases were identified through linkage to the California Cancer Registry and self-report. Written consent was obtained from 116 F0 and 95 F1 breast cancer survivors to access their pathology reports and tumor blocks. Of those contacted, 62% consented, 13% refused and 24% did not respond. We obtained tissue samples for 57% and pathology reports for 75%, and if diagnosis was made ⩽10 years we obtained tissue samples and pathology reports for 91% and 79%, respectively. Obtaining pathology reports and tumor tissues of two generations is feasible and will support investigation of the relationship between early-life exposures and molecular tumor markers. However, we found that more recent diagnosis increased the accessibility of tumor tissue. We recommend that cohorts request consent for obtaining future tumor tissues at study enrollment and implement real-time tissue collection to enhance success of collecting tumor samples and data.

Keywords

breast cancer preventionChild Health and Development Studiespathology reportsPEDIGREE studytumor sample collection
Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 8 , Issue 3 , June 2017 , pp. 331 - 336
Check for updates
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

†

Authors contributed equally to this work.

References

1. Russo, IH, Russo, J. Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia. 2011; 16, 221–233.Google Scholar
2. Russo, J, Moral, R, Balogh, GA, Mailo, D, Russo, IH. The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005; 7, 131–142.Google Scholar
3. Cohn, BA, Wolff, MS, Cirillo, PM, Sholtz, RI. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect. 2007; 115, 1406–1414.Google Scholar
4. Cohn, BA, La Merrill, M, Krigbaum, NY, et al. DDT exposure in utero and breast cancer. J Clin Endocrinol Metab. 2015; 100, 2865–2872.Google Scholar
5. van den Berg, BJ, Christianson, RE, Oechsli, FW. The California Child Health and Development Studies of the school of public health, University of California at Berkeley. Paediatr Perinat Epidemiol. 1988; 2, 265–282.Google Scholar
6. Personal communication with Lisa Godefroy Johnsonto receive the Women’s Health Initiative consent rates, 2015.Google Scholar
7. Personal communication with Meir Stampfer to receive the Health Professionals Follow-up Study consent rates, 2015.Google Scholar
8. Personal communication with Meir Stampfer to receive the Nurses’ Health Study consent rates, 2015.Google Scholar
9. Personal communication with Cynthia A. Kleeberger to receive The Sister Study consent rates, 2015.Google Scholar
10. Krieger, N, Habel, LA, Waterman, PD, et al. Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947–2009). NPJ Breast Cancer. 2015; 1, 15016.Google Scholar
11. Policies and procedures for access to and disclosure of confidential data from the California Cancer Registry, 2014. Retrieved 23 September 2015 from http://www.ccrcal.org/pdf/Data_Statistics/CCRPoliciesProcedures_v05.1.pdf.Google Scholar
12. College of American Pathologists. Laboratory of Pathology Online Policy Manual, CAP & CLIA Retention Requirements. Retrieved 16 June 2014 from http://home.ccr.cancer.gov/lop/intranet/policymanual/generalpolicy/CAPCLIA.asp.Google Scholar
Supplementary material: File

Krigbaum supplementary material

Table S1

Download Krigbaum supplementary material(File)
File 14.2 KB